Pyxis Oncology, Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Pyxis Oncology, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2020 to 2023.
  • Pyxis Oncology, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$17.3M, a 8.8% decline year-over-year.
  • Pyxis Oncology, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$59.2M, a 40.2% increase year-over-year.
  • Pyxis Oncology, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$73.8M, a 38.9% increase from 2022.
  • Pyxis Oncology, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$121M, a 58.9% decline from 2021.
  • Pyxis Oncology, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$76M, a 492% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$73.8M +$46.9M +38.9% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-21
2022 -$121M -$44.7M -58.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-21
2021 -$76M -$63.1M -492% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-22
2020 -$12.8M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.